静脉乙醇输液用于消除心房动:一个逐步指南
Apoor Patel1, Adi Lador1, Miguel Valderrábano1
1Houston Methodist DeBakey Heart and Vascular Center, Division of Cardiac Electrophysiology, Houston, Texas, USA.
Journal of cardiovascular electrophysiology
|July 9, 2025
概括
肺静脉隔离单独对持续性心房动 (AF) 有有限的成功. 马歇尔静脉 (VOM) 乙醇输液是一种辅助策略,可以提高切除效率,减少AF复发.
科学领域:
- 电子生理学 电子生理学
- 心脏病学 心脏病学
- 医疗程序 医疗程序
背景情况:
- 肺静脉隔离 (PVI) 单独显示在治疗持久性心房动 (AF) 的有效性有限.
- 辅助策略是必要的,以改善持续AF管理的结果.
- 马歇尔静脉 (VOM) 已成为辅助治疗的潜在目标.
研究的目的:
- 为执行VOM乙醇输注提供标准化,逐步指南.
- 概述一个可重复的框架,将VOM乙醇切除整合到临床实践中.
- 为了提高AF切除手术的疗效.
主要方法:
- 该指南详细介绍了静脉通道,冠状动脉鼻通道和VOM识别.
- 乙醇是使用一个无线气球导管系统注入的.
- 该程序的重点是优化VOM乙醇输注的输送和安全性.
主要成果:
- VOM乙醇输液增强了肺静脉隔离的疗效.
- 这种辅助策略降低了AF复发率.
- 它提高了实现持久的 mitra 胸阻塞的可能性.
结论:
- VOM乙醇输液是持续性AF的有价值的辅助疗法.
- 标准化的协议有助于整合VOM乙醇除.
- 这种方法优化了复杂的AF患者的节律控制策略.
相关概念视频
Hemodialysis I: Introduction
310
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
310
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Varicose Veins II: Diagnostic Studies and Interprofessional Care
37
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
37
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
170
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
170
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
594
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
594
Cardiopulmonary Resuscitation IV: Pharmacological Management
81
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
81


